Clinical and molecular genetic characterization of wild-type MLL infant acute lymphoblastic leukemia identifies few recurrent abnormalities

Marieke H van der Linden; Judith M Boer; Pauline Schneider; Merel Willekes; Lidija Seslija; Paola De Lorenzo; Maria Grazia Valsecchi; Giovanni Cazzaniga; Andrea Biondi; Monique L den Boer; Rob Pieters; Ronald W Stam

doi:10.3324/haematol.2014.122119

Clinical and molecular genetic characterization of wild-type MLL infant acute lymphoblastic leukemia identifies few recurrent abnormalities

Marieke H van der Linden, Judith M Boer, Pauline Schneider, Merel Willekes, Lidija Seslija, Paola De Lorenzo, Maria Grazia Valsecchi, Giovanni Cazzaniga, Andrea Biondi, Monique L den Boer, Rob Pieters, Ronald W Stam

Group Pieters

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review

14 Citaten (Scopus)

Originele taal-2	Engels
Pagina's (van-tot)	e95-8
Tijdschrift	Haematologica
Volume	101
Nummer van het tijdschrift	3
DOI's	https://doi.org/10.3324/haematol.2014.122119
Status	Gepubliceerd - mrt. 2016

Toegang tot document

10.3324/haematol.2014.122119

Citeer dit

van der Linden, M. H., Boer, J. M., Schneider, P., Willekes, M., Seslija, L., De Lorenzo, P., Valsecchi, M. G., Cazzaniga, G., Biondi, A., den Boer, M. L., Pieters, R., & Stam, R. W. (2016). Clinical and molecular genetic characterization of wild-type MLL infant acute lymphoblastic leukemia identifies few recurrent abnormalities. Haematologica, 101(3), e95-8. https://doi.org/10.3324/haematol.2014.122119

@article{a4aa8ffe0e794126b3f95883ef1c4b18,

title = "Clinical and molecular genetic characterization of wild-type MLL infant acute lymphoblastic leukemia identifies few recurrent abnormalities",

keywords = "Antineoplastic Agents, Hormonal/therapeutic use, B-Lymphocytes/drug effects, Comparative Genomic Hybridization, DNA Copy Number Variations, Female, Gene Expression Profiling, Gene Expression Regulation, Leukemic, Homeodomain Proteins/genetics, Humans, Immunophenotyping, Infant, Infant, Newborn, Male, Mutation, Myeloid Ecotropic Viral Integration Site 1 Protein, Neoplasm Proteins/genetics, Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, Prednisone/therapeutic use, Survival Analysis, Treatment Outcome",

author = "{van der Linden}, {Marieke H} and Boer, {Judith M} and Pauline Schneider and Merel Willekes and Lidija Seslija and {De Lorenzo}, Paola and Valsecchi, {Maria Grazia} and Giovanni Cazzaniga and Andrea Biondi and {den Boer}, {Monique L} and Rob Pieters and Stam, {Ronald W}",

year = "2016",

month = mar,

doi = "10.3324/haematol.2014.122119",

language = "English",

volume = "101",

pages = "e95--8",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "3",

}

van der Linden, MH, Boer, JM, Schneider, P, Willekes, M, Seslija, L, De Lorenzo, P, Valsecchi, MG, Cazzaniga, G, Biondi, A, den Boer, ML , Pieters, R & Stam, RW 2016, 'Clinical and molecular genetic characterization of wild-type MLL infant acute lymphoblastic leukemia identifies few recurrent abnormalities', Haematologica, vol. 101, nr. 3, blz. e95-8. https://doi.org/10.3324/haematol.2014.122119

TY - JOUR

T1 - Clinical and molecular genetic characterization of wild-type MLL infant acute lymphoblastic leukemia identifies few recurrent abnormalities

AU - van der Linden, Marieke H

AU - Boer, Judith M

AU - Schneider, Pauline

AU - Willekes, Merel

AU - Seslija, Lidija

AU - De Lorenzo, Paola

AU - Valsecchi, Maria Grazia

AU - Cazzaniga, Giovanni

AU - Biondi, Andrea

AU - den Boer, Monique L

AU - Pieters, Rob

AU - Stam, Ronald W

PY - 2016/3

Y1 - 2016/3

KW - Antineoplastic Agents, Hormonal/therapeutic use

KW - B-Lymphocytes/drug effects

KW - Comparative Genomic Hybridization

KW - DNA Copy Number Variations

KW - Female

KW - Gene Expression Profiling

KW - Gene Expression Regulation, Leukemic

KW - Homeodomain Proteins/genetics

KW - Humans

KW - Immunophenotyping

KW - Infant

KW - Infant, Newborn

KW - Male

KW - Mutation

KW - Myeloid Ecotropic Viral Integration Site 1 Protein

KW - Neoplasm Proteins/genetics

KW - Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy

KW - Prednisone/therapeutic use

KW - Survival Analysis

KW - Treatment Outcome

UR - http://www.scopus.com/inward/record.url?scp=84959269455&partnerID=8YFLogxK

U2 - 10.3324/haematol.2014.122119

DO - 10.3324/haematol.2014.122119

M3 - Article

C2 - 26681762

SN - 0390-6078

VL - 101

SP - e95-8

JO - Haematologica

JF - Haematologica

IS - 3

ER -